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Expression of the transcriptional regulator Egr-1 in experimental
glomerulonephritis: Requirement for mesangial cell proliferation. The
early growth response gene-i (Egr-i), a zinc finger transcriptional regu-
lator, was induced in a rat model of mesangioproliferative glomerulone-
phritis (GN). Northern blot analysis revealed a maximal 14.9-fold increase
in glomerular Egr-i mRNA at day 6 of ON. By immunohistochemistry
Egr-1 protein expression was demonstrated to be mainly confined to
glomerular mesangial cells (MC). To test whether Egr-i directly regulates
MC proliferation, cultured MCs were stimulated with platelet-derived
growth factor (PDGF) after preincubation with different Egr-1 antisense
oligonucleotides (ASOs). PDGF-induced Egr-1 mRNA levels were inhib-
ited by up to 75% and protein levels by up to 91%. In addition
Egr-i-specific ASOs blocked PDGF-induced rise in 3H-thymidine uptake
by 83% and almost completely abrogated increase in MC number. We
conclude that Egr-i induction is of critical importance for PDGF-induced
mitogenic signaling in MCs, and inhibition of Egr-1 in vivo may offer an
approach to oppose glomerular MC proliferation in glomerular inflam-
matory disease.
A common reaction pattern of various glomerular kidney
diseases—be the original insult of immunological, toxic or meta-
bolic nature—is increased proliferation of intrinsic mesangial cells
(MCs) and mesangial hypercellularity. Examples include IgA
nephropathy, membranoproliferative glomerulonephritis, postin-
fectious endocapillary proliferative glomerulonephritis, lupus ne-
phritis, diabetic nephropathy and focal segmental glomeruloscle-
rosis. Persistent mesangial hypercellularity together with
increased matrix deposition is considered an important factor in
progressive glomerular sclerosis and deterioration in renal func-
tion. In various animal models of glomerular disease stimulation
of MC proliferation resulted in increased deposition of extracel-
lular matrix, and interventions inhibiting proliferation also
blocked matrix expansion [1, 2]. In view of these findings, our
work addresses two key questions: (1.) What arc the molecular
mechanisms regulating MC proliferation in vitro and in vivo? (2.)
How can MC proliferation be inhibited or prevented and how can
resolution of mesangial hypercellularity be achieved?
In previous studies, we could demonstrate a very close corre-
lation between the proliferative response of cultured rat MCs and
the induction of the early growth respone gene-i (Egr-1) [3, 4].
Furthermore, inhibitors of MC growth, like atrial natriuretic
peptide or dexamethasone, inhibited Egr-i mRNA induction
(H.D. Rupprecht, unpublished observations). Egr-1, also known
as zif268, Krox 24, TIS 8 or NGFI-A, is a member of the family of
immediate early genes. It is rapidly and transiently induced after
a variety of mitogenic signals [3, 5], but also during fetal devel-
opment in the mouse [6], following differentiation signals [7, 8],
after ionizing radiation [91, or in response to stretch/relaxation
[101. Induction has been shown to occur mainly at the transcrip-
tional level [4, 11, 121. The gene encodes a 75 to 80 kDa nuclear
phosphoprotein [13, 14], which has been shown to bind DNA at
the consensus sequence GCGGGGGCG in a zinc-dependent
fashion through three zinc-finger domains [14—16] and to activate
transcription [14, 17—19].
The present study demonstrates that Egr-1 induction not only
occurs after mitogenic stimulation of MCs in culture, but can also
be observed with MC proliferation in vivo during the course of
anti-Thy-i nephritis, a rat model of mesangioproliferative glomer-
ulonephritis. Using an antisense oligonucleotide strategy, we
provide evidence that Egr-1 induction is not a mere epiphenom-
enon of MC proliferation, but is an essential part of the mitogenic
signal transduction cascade elicited by PDGF in cultured MCs.
Methods
Experimental disease
Inbred male Sprague-Dawley rats (150 to 200 g) were obtained
from Charles River Deutschland (Sulzfeld, Germany). Monoclo-
nal antibody against Thyl.1 (ER4) is described elsewhere [20].
Anti-Thy-i nephritis was induced by a single intravenous injection
of 1 mg/kg body wt of ER4 into the tail vein. Groups of four
animals were sacrificed on days 2, 6 and 12 after induction of
nephritis and renal tissue was obtained for immunohistochemistry
or RNA extraction. A group of four normal animals served as a
control.
Immunohistochemistiy
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Five-micrometer cryostat kidney sections were air dried for 10
minutes, fixed in 3% paraformaldehyde for five minutes, incu-
bated with 0.1% Triton X100 for 10 minutes, and subsequently in
5% fetal calf serum and 5% normal goat serum in phosphate
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buffered saline (PBS) for 20 minutes. For Egr-1 staining sections
were incubated for 120 minutes with polyclonal anti-Egr-1 anti-
body R5232-2 (1:150), as described in detail elsewhere [13],
followed by a 30 minute incubation with tetramethyirhodamin
isothiocyanate (TRITC)-conjugated goat anti-rabbit antibody (1:
200; Nordic Immunological Laboratories, Tilburg, Netherlands).
The anti-Egr-1 antibody was provided by Dr. V.P. Sukhatme
(Beth Israel Hospital, Boston, MA, USA). For double label
immunofluorescence stainings, sections were either incubated
with monoclonal antibody OX-7 (recognizing the Thyl.1 epitope
on MCs; 1:200; PharMingen, San Diego, CA, USA) or ED-I
(recognizing monocytes/macrophages; 1:1500), descibed in detail
elsewhere [21], for 60 minutes and fluorescein isothiocyanate
(FITC)-conjugated goat F(ab')2 anti-mouse IgGi antibody (1:
100; Nordic) for 30 minutes, followed by incubation with anti-
Egr-1 antibody R5232-2 (1:150) for 120 minutes and TRITC-
conjugated goat anti-rabbit antibody (1:200; Nordic) for 30
minutes. All antibodies were diluted in PBS containing 1% bovine
serum albumin and 0.5% Tween.
.4ntisense oligonucleotides
Phosphothioate-modified antisense and sense, scrambled or
mismatched control oligodeoxynucleotides (ODNs) were from
MWG Biotech (Ebersberg, Germany) and were dissolved in H20.
ODNs were applied 16 hours prior to stimulation of MCs. The
sequences of the ODNs used and the positions relative to the
translational AUG start site are as follows:
AS1: 5'-GCGGGGTGCAGGGGCACACT-3' (-118 to -99),
SI: 5' -AGTGTGCCCCTGCACCCCGC-3',
5CR 1: 5 '-AGGCTGGCTGCCGGGAGCGA-3',
AS2: 5'-TTACATGCGGGGTGC-3' (-107 to -93),
AS2M: 5 '-TTAGATGCGGGGTCC-3',
AS3: 5'-CGGCCTT'GGCCGCTGCCAT-3' (1 to 19),
S3: 5 '-ATGGCAGCGGCCAAGGCGG-3',
AS4: 5'-GGGTTGGTCATGCTC-3' (485 to 499).
Mesangial cell isolation and culture
Glomeruli from rat kidneys were isolated and glomerular
outgrowth and subsequent subculturing of MCs were performed
as previously described [3]. MCs were kept in Dulbecco's modified
Eagle's medium supplemented with 10% heat inactivated (50°C,
30 mm) fetal calf serum (FCS), 50 U/mI penicillin, 50 jig/mI
streptomycin, 2 mrvt glutamin, 5 jig/mI insulin in a 95% air-5%
CO2 humidified atmosphere at 37°C. MCs were used for experi-
ments between passages 5 and 20.
RNA extraction and Northern blot analysis
MCs were grown in 10 cm dishes until suhcontluency and
growth arrested for 72 hours in medium containing 0.4% FCS.
After adequate stimulation cells were washed twice in phosphate
buffered saline (PBS) and total RNA was extracted by the method
of Chomczynski and Sacehi [22]. For the extraction of glomerular
RNA renal cortex was dissected from kidneys from experimental
animals, sacrificed at various time points after disease induction,
and glomeruli were isolated by the sieving technique as previously
described [3]. RNA was size-fractionated on a 1% agarose
formaldehyde gel and transferred onto Hyhond nylon membranes
(Amersham, Little Chalfont). The Northern blot was baked at
80°C for two hours, prehybridized with 5X Denhardt's solution,
Fig. 1. Egr-J mRNA expression during the course of anti-Thy-] nephritis.
Total RNA was extracted from glomeruli isolated by the differential
sieving technique from control rats or from animals rendered nephritic by
a single injection of anti-Thyl.1 antibodies at day 2,6 or 12. RNA obtained
from 4 animals per time point was pooled and 15 pg RNA were
size-fractionated on an agarose gel and blotted. A. Northern blot was
probed for Egr-1 or GAPDH to control for equal loading. B. Expression
levels for Egr-1 were quantified by densitometric analysis and are cx--
pressed as relative densitometric units corrected for expression of
GAPDH. Egr-1 expression under control conditions was defined as one
densitometric unit.
5 X SSC, 50% formamide, 50mM Na3PO4, 0.1% SDS, 0.25 mg/mI
salmon sperm DNA at 39°C for four hours. DNA hybridization
probes were labeled with [s-32P]dCTP using a random primed
labeling kit (Boehringer Mannheim, Manriheim, Germany). The
blots were hybridized in prehybridization solution containing 2 X
106 cpm/ml of probe at 39°C for 20 hours. The blot was washed
twice for 15 minutes with 2 X SSC containing 0.1% SDS and then
30 minutes with 0.1 X SSC containing 0.1% SDS. Blots were
exposed to Kodak XAR-2 films with intensiTing screens at
—80°C.
Protein extraction arid Western blot analysis
MCs were grown in 3.5 cm dishes until subconfiuency, growth
arrested for 72 hours in medium containing 0.4% FCS and
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Fig. 2. Immunofluorescence of cryosections showing Egr-1 expression during
anti-Thy-i nephritis. (A) Representative glomerulus of control animal
showing no or very weak nuclear Egr-1 staining. (B) Representative
glomerulus six days after disease induction showing clear nuclear staining
of multiple glomerular cells in mesangial location and (C) non-represen-
tative glomerulus showing very bright nuclear Egr-1 staining in isolated
glomerular cells locating to the mesangium. (D) Isolated tubular cells six
days after disease induction showing nuclear Egr-1 staining (magnification
X400). Paraformaldehyde-fixed frozen sections were incubated with a
polyclonal anti-Egr-1 antibody for 120 minutes, followed by a 30 minute
incubation with a TRITC-conjugated goat anti-rabbit antibody.
harvested after adequate stimulation in 100 jxl RIPA solution (1%
Triton X-100, 1% sodiumdeoxycholate, 0.1% SDS, 0.15 M NaCI,
50 mM Tris-HC1, pH 7.2, 10 mrvt EDTA, pH 7.2, 1 mtvt PMSF,
leupeptin 2 xg/ml). Protein concentration was determined using
the Bradford assay (Bio-Rad, Hercules). Protein samples contain-
ing 20 sg total protein were denatured by boiling for five minutes
and separated on a 7.5% denaturing SDS-PAGE gel. After
electrophoresis, the gels were electroblotted onto NC membranes
and the transfer was controlled by Ponceau-S staining. Blots were
incubated in PBS containing 0.1% Tween-20 and 5% nonfat dry
milk powder to block unspecific binding, washed in PBS Contain-
ing 0.1% Tween-20 and incubated with the primary anti-Egr-1
antibody R5232-2 (1:3000), described in detail elsewhere [131.
Egr-1 was visualized with a secondary horseradish peroxidase-
conjugated anti-rabbit lgG antibody using the ECL system (Am-
ersham).
Determination of 311-thymidine uptake
MCs were subcultured in 96-well plates in medium supple-
mented with 10% FCS until subconflueney and growth-arrested
for 72 hours in medium supplemented with 0.4% FCS. Quiescent
MCs were then exposed to fresh medium Containing 0.4% FCS
with and without ODNs for an additional 16 hours before
stimulation with agonists. Cells were pulsed with I rCi/ml [3H-
methyl-thymidine (specific activity 5 mCi/mmol; ICN, Hyland,
TX, USA) from 0 to 24 hours after addition of agonists. The cells
i . . l  l l im unofluorescence for Egr-i and hyi. I or Egr-I and
m000cytes of frozen sections six days after induction of anti-Thy-i nephrais.
(A) glomcrular expression of Egr-1 (polyclonal rabbit anti-Egr-1 antibody!
TRITC-conjugated goat anti-rabbit antibody) and (B) the mesangial cell
epitope Thy 1.1 (mouse monoclonal antibody OX-7/FITC-conjugated goat
F(ab')2 anti-mouse IgGi antibody) showing many Egr-1 +/OX-7+ cells
(some marked by arrowheads). (C) Glomerular expression of Egr-1 and
(D) the monocyte/macrophage marker ED-i (mouse monoclonal antibody
ED-1/FITC-conjugated goat F(ab')2 anti-mouse IgGi antibody) showing
two Egr-1+/ED-1+ cells (marked by arrowheads), whereas most Egr-1-
expressing cells were of non-macrophage origin (Egr-1+/ED-1--). A and
B or C and D each show an identical area of the same section viewed
through different filters for visualization of TRITC- or FITC-conjugated
antibodies.
were washed twice with PBS, lysed with distilled water and
harvested onto filters by an automated cell harvester (Bibby
Dunn, Watertown, MA, USA). Incorporated counts were mea-
sured by a liquid scintillation counter (Beckmann, Fullerton, CA,
USA).
Determination of cell number
MCs were seeded in 96-well plates at a density of 3 X IO
cells/well and growth arrested for 72 hours in medium supple-
mented with 0.4% FCS. Stimulation of MCs was performed as for
3H-thymidinc uptake. Cell number was determined 72 hours after
growth stimulation. Monolayers were washed twice in PBS, cells
were trypsinized and transferred into 10 ml of Isoton for counting
in a coulter counter (Coulter, Luton).
Statistical analysis
Statistical analysis was performed using the Student's t-test for
unpaired samples.
Results
Glomerular expression of Egr- I mRNA in experimental
mesangioproliferative glomerulonephritis
We recently reported a close correlation between the induction
of Egr-1 mRNA expression and MC growth by a number of
Fig. 4. Inhibition of PDGF-induced Egr-1
mRNA expression in cultured rat mesangial cells
by antisense oligonucleotides against Egr-1.
Growth arrested MCs were preincubated for 16
hours with 8 /LM Egr-1 antisense
oligonucleotides (AS1, AS2) or sense (Si) or
scrambled (SCR1) control oligonucleotides
before stimulation with PDGF 20 ng/ml for one
hour. Total RNA was harvested and size-
fractionated on an agarose gel. A. Northern
blot was probed for Egr-1 (upper panel), c-jun
(middle panel) or GAPDH (lower panel). B.
Relative densitometric units corrected for
GAPDH expression are given (Egr-1 expression
after PDGF-stimulation without prcincubation
with oligonucleotides 1).
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mitogenic, vasoactive peptides 131. To test whether Egr-1 expres-
sion also occurred in vivo, we determined Egr-1 transcript levels
during the course of anti-Thy-i nephritis, an experimental model
of mesangioproliferative glomerulonephritis elicited by a single
injection of monoclonal antibody ER 4. This model is character-
ized by initial mesangiolysis and acute inflammation followed by a
phase of predominant MC proliferation peaking at days 3 to 6
after disease induction [20, 231. Disease progression was moni-
tored by measurement of 24-hour urinary protein excretion
(mean SD; N = 4; controls, 8.7 2.1 mg/day; Thy-i at day 2,
129.5 164.6 mg/day; at day 6, 277.4 76.5 mg/day; at day 12,
109.4 30.1 mg/day), which was comparable to that reported in
the literature [201. Total RNA was harvested from whole kidneys
or from isolated glomeruli and Northern blot was probed for
Egr-i. No significant change in Egr-1 mRNA expression between
control animals and animals six days after disease induction was
observed when RNA was isolated from total kidneys (data not
shown). However, if RNA was extracted from isolated glomeruli,
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Fig. 5. Inhibition of PDGF-induced Egr-1 protein expression in cultured rat mesangial cells by antisense oligonucleotides against Egr-J. Growth arrested
MCs were preincubated for 16 hours with 8 rM Egr-l antisense oligonucleotides (AS) or sense (S), scrambled (SCR) or mismatched (ASM) control
oligonucleotides before stimulation with PDGF 20 nglml for two hours. A. Twenty milligrams of protein were size fractionated on a SDS-PAGE gel and
Egr-1 was visualized on Western blots using the ECL system (Amersham). B. Relative densitometric units are given (Egr-1 expression after
PDGF-stimulation without addition of oligonucleotides = 1). A representative of three experiments is shown for antisense oligonucleotides AS 1 and
A52. The Western blot with antisense oligonucleotide AS3 was only performed once.
a maximal 14.9-fold increase in Egr-1 mRNA expression was
observed on day 6 after induction of anti-Thy-i nephritis (Fig. 1).
This demonstrates that Egr-1 mRNA is up-regulated in an
experimental model of mesangioproliferative nephritis and is of
predominant glomerular origin.
Egr- / protein expression in anti-Thy-i nephritis is predominantly
up-regulated in glon'ierular rnesangial cells
To identify the cell type expressing Egr-l, immunohistochem-
istry was performed on paraformaldehyde-fixed cryostat kidney
sections. Control animals showed virtually no or only very weak
nuclear staining within the glomeruli, and no staining was ob-
served in tubular cells (Fig. 2A). Six days after induction of
anti-Thy-i nephritis, a marked increase in nuclear staining of
multiple cells was observed within the glomeruli (Fig. 2B). The
time course of Egr-i protein expression paralleled that of Egr-l
mRNA induction. Only a marginal increase in nuclear staining
was observed on day 2, and the maximum staining was detected on
day 6 after disease induction and decreased thereafter. On day six
of nephritis, but not on days 2 or 12, some scattered tubular cells
were tound to express Egr-i protein (data not shown). Double
label immunofluorescence staining demonstrated that must Egr-i
expressing cells were also Thyl.l-positive, identifying them as
mesangial cells (Egr-1 +/OX-7+) (Fig. 3 A, B). To test whether in
addition to MCs infiltrating monucytes expressed Egr-1 we per-
formed stainings with the monocyte/macrophage marker ED-i.
We found 0.77 0.67 ED-I + cells per glomerular cross section
(GCS) in control animals, 7.86 3.36 cells/GCS on day 2, 4.29
2.68 cells!GCS on day 6, and 1.45 1.37 ED-i + cells/GCS on day
12 (mean so; N = 30). Double label immunofluorescence
staining for Egr-l and ED-i revealed the presence of few Egr-
1+/ED-i + cells. Most Egr-1 positive cells, however, did not stain
for the monocyte/macrophage marker ED-i (Fig. 3 C, D). These
results identify the majority of Egr-1 expressing glomerular cells
as MCs. However, few monocyte/macrophages also contribute to
glomerular Egr-l expression in anti-Thy-i nephritis.
PDGF+AS1 PDGF+S1:ontroi PDGF
Rupprecht et al: Egr-1 and mesangial cell proliferation 699
Fig. 6. Inhibition of PDGF-induced nuclear Egr-1 protein expression by antisense oiligonucleotides against Egr-1. Immunofluorescence of cultured MCs
seeded on chamber slides showing Egr-l expression after 16 hours preincubation with Egr-1 antisense (AS) or sense (5) or scrambled (SCR) control
oligonucleotides (8 /xM) and stimulation with PDGF 20 nglml for two hours. A representative of three independent experiments is shown.
Antisense oligonucleotides directed against Egr-1 inhibit mRNA
and protein expression in cultured MCs
To elucidate the function of Egr-1 in the mitogenic signal
transduction cascade in cultured MCs, we attempted to eliminate
Egr-1 by the application of antisense oligonucleotides (ODN)
directed against Egr-1. Preincubation of quiescent MCs with
antisense ODN AS1 or AS2 for 16 hours prior to PDGF stimu-
lation for one hour inhibited Egr-l mRNA levels by 54% and
75%, respectively (Fig. 4). Sense or scrambled control ODNs were
without significant effects. The induction of another immediate
early gene, c-fun, was not affected. Since the efficacy of antisense
oligonucleotides depends on elimination of the target protein,
Western blot anlaysis was performed. AS1 inhibited PDGF-
induced Egr-1 protein levels by 91% 9% (N = 3; Fig. 5). Two
other antisense ODNs, AS2 and AS3, inhibited Egr-1 protein
induction by 55% 8% (N = 3) and 74% (N = 1), respectively.
Again sense (Si, S3), scrambled (SCR1), as well as a mismatched
control ODN (AS2M) had no detectable effect on Egr-1 protein
induction (Fig. 5). We also tested the effects of Egr-1 antisense
ODNs on PDGF-induced Egr-1 protein levels by immunocyto-
chemistry to demonstrate that indeed nuclear accumulation of
Egr-I was prevented. A clear decrease in PDGF-induced nuclear
staining for Egr-1 was observed when MCs were preincuhated
with antisense ODNs (AS1, AS2; Fig. 6).
Antisense oligonucleotides against Egr-1 potently inhibit inesangial
cell proliferation
To examine whether suppression of Egr-1 mRNA and protein
induction interfered with MC mitogenesis, we tested the effect of
Egr-1 antisense oligonucleotides on PDGF-induced MC prolifer-
ation measured by 3H-thymidine uptake (Fig. 7A) and cell counts
(Fig. 7B). 3H-thymidine uptake was dose-dependently inhibited
by antisense oligonucleotidcs AS1, AS2 and AS3 in a concentra-
tion range from I to 8 ELM. The respective control oligonucleotides
(8 jiM) were without significant effects. Consistent with these
results, antisense oligonucleotides also significantly inhibited
PDGF-induced increase in MC number. Again, control oligonu-
cleotides were ineffective. A summary of the effects of the
different antisense oligonucleotides on PDGF-induced Egr-1 pro-
tein expression and 3H-thymidine uptake is given in Table 1.
Antisense oligonucleotides maximally inhibiting Egr-i protein
expression proved to be the most effective inhibitors of MC
growth. Likewise, Egr-1 antisense oligonucleotides that were less
effective inhibitiors of PDGF-induced Egr-1 protein expression
suppressed MC growth to a lower extent.
Discussion
Glomerular mesangial cell hypercellularity is considered one of
the critical early pathogenetic events leading to progressive gb-
merular scarring, loss of renal function and end-stage renal
disease. Here we demonstrate a marked up-regulation of the
transcriptional regulator Egr-1 in an in vivo model of mesangio-
proliferative glomerulonephritis. The well established and highly
reproducible anti-Thy-I model, elicited by a single injection of
monoclonal antibody ER4, was chosen for this purpose. The
model is characterized by a pronounced mesangial proliferative
response after an initial mesangiolytic phase. MC proliferation, as
determined by staining for the bDNA polymerase accessory
protein PCNA (proliferating cell nuclear antigen), peaks at
around days 3 to 6 after induction of the model [24—271. Exam-
ining glomerular total RNA, we found a maximum 15-fold
increase in Egr-1 mRNA expression on day 6 after disease
induction, demonstrating that in vivo Egr-i mRNA expression in
anti-Thy-i nephritis is largely restricted to the glomerular com-
partment, and that peak expression correlates with the time point
of maximal MC proliferation reported [2, 25,26]. These data were
confirmed by immunohistochemistry, which identified the major-
ity of Egr-i protein expressing cells as mesangial cells. A few cells
exhibited double staining for ED-i and Egr-1, indicating that in
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Table 1. Effects of various antisense oligonucteotides directed agaiost
Egr-1 On PDGF-stimulated Egr-1 proteio expression aod MC growth
% Inhibition AS1 AS2 AS3 AS4
Egr-1 proteio 91% 9% 55% 8% 74% 24%
(Western blot) (N = 3) (N 3) (N 1) (N 1)
311-thymidine 83% 40% 44% 9% 75% 32% 33%
uptake (N3) (N=3) (N5) (N I)
Quiescent Mfl wcre incubated for 16 hours with the indicated aoti-
sense oligonuclcutides (8 gu) hefore stimulation with PDC+F (2t) ng/ml).
Total cellular protein for Western blotting was extracted 2 hours after
PDQF-stimulation. Egr-1 expression was quantitatcd hy densitnmetry and
the percent inhibition relative to PDCF-stimulated controls without
addition of oligonueleotides is given. 3H-thymidine incorporation was
measured in the time interval from 0 to 24 hours after PDGF-stimulation
(N = number of independent experiments each consisting of 5 samples).
addition to MCs, infiltrated macrophages can contribute to gb-
merular Egr-i expression. Expression of Egr-1 by activated mac-
rophages in culture has previously been shown by us and others [8,
Fig. 7. Dose-dependent inhibition of MC
proliferation by antisense oligonucleotides against
Egr-1. MCs were seeded in 96-well plates,
serum deprived for 72 hours, preineubated for
16 hours with the indicated concentrations of
antisense (AS) or control sense (5), scrambled
(SCR) or mutated (ASM) oligonucleotides and
then stimulated with PDGF 20 ng/ml. MC
proliferation was assessed by (A) 3H-thymidine
incorporation measured from 0 to 24 hours
after PDGF-stimulation and (B) obtaining cell
counts 72 hours after the addition of PDGF.
Values given are means sn of five samples.
Significanees were calculated comparing PDGF-
stimulated cells after preineubation with
oligonucleotides to PDGF-stimulated cells
without the addition of oligonueleotides. N.S. is
nonsignificant. *p < 0.05, < 0.01, ***p <
0.001.
28]. Since the number of maerophages per gbomerular cross
section peaked on day 2 after induction of nephritis, declining
rapidly thereafter, whereas Egr-1 mRNA expression was only
marginal at day 2 and peaked at day 6, it is unlikely that
maerophages are a major source of gbomerular Egr-l. As expected
by the biological function of Egr-1 as a DNA-binding transcrip-
tional regulator, staining was clearly nuclear.
In a next objective we tried to elucidate whether the observed
expression of the transcriptional activator Egr-1 bears functional
relevance for MC growth induction, Egr-1 antisense oligonueleo-
tides were used to block Egr-1 expression in cultured rat MCs.
PDGF was chosen as the mitogenic stimulus, since it is one of the
most potent MC mitogens in vitro and since it had been demon-
strated by antibody infusion that PDGF is one of the major
cytokines involved in MC proliferation in the ATS (anti-thymo-
cyte serum) model of glomerulonephritis [29]. Furthermore, our
own previous studies showed that cultured MCs express high
levels of Egr-I mRNA after PDGF stimulation [3]. Here we
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demonstrate that phosphothioate-modified antisense oligonucle-
otides directed against Egr-1 prevent or diminish PDGF-induced
increase in Egr-1 mRNA and protein levels. The effect was
dose-dependent in a concentration range from 1 to 8 M. AS
oligonucleotides also potently inhibited MC growth as measured
by 3H-thymidine uptake and cell counts in a dose-dependent
fashion.
We included several controls to provide conclusive evidence for
the specificity of the observed effects: (1.) Inhibition of Egr-i was
shown on mRNA and protein level. (2.) Egr-I, but not another
immediate early gene, c-jun, was inhibited by Egr-1 AS oligonu-
cleotides. (3.) Inhibition at the protein level was also shown by
immunocytochemistry, proving that indeed nuclear staining for
Egr-1 was abolished. We felt this was necessary since the existence
of a 54 kDa cytoplasmic form of Egr-1, which cannot function as
a transcriptional regulator, has been reported in PC12 cells [301.
(4.) Sense, scrambled and mismatched oligonucleotides served as
controls for nonspecific effects and had no significant impact on
Egr-1 mRNA, protein levels or MC growth. (5.) A number of
different Egr-I antisense oligonucleotides was tested. We ob-
served a clear correlation between the ability of the various
oligonucleotides to inhibit Egr-1 protein expression and their
ability to inhibit PDGF-induced growth. Since several different
oligonucleotides were effective it is unlikely that target genes
other than Egr-1 were responsible for the observed effect.
Some of the oligonucleotides used in our study contain a stretch
of four consecutive guanine residues. During the course of this
study Burgess et al reported that AS oligonucleotides directed
against c-myc and c-myb containing such stretches of four guanine
residues might inhibit proliferation of smooth muscle cells due to
a non-antisense mechanism [31]. Several reasons argue against
major nonspecific effects of antisense ODNs used in our study:
(1.) We demonstrate that oligonucleotides not carrying four
consecutive guanine residues effectively inhibit Egr-I protein and
MC growth. (2.) When we introduced two base pair mismatches
into an AS oligonucleotide containing four guanine residues,
leaving the stretch of four guanirie residues in place, this mis-
matched oligonucleotide was no longer capable of modulating
Egr-I protein levels or MC proliferation. (3.) We found a
consistently close correlation between the abiltiy of the oligonu-
cleotides to inhibit Egr-l protein and their ability to suppress MC
growth.
Our in vitro studies in cultured MCs demonstrate that induction
of Egr-i is a necessary step in the PDGF-induced mitogenic signal
transduction cascade. Antisense oligonucleotides to Egr-I could
offer the possibility to interfere with MC proliferation, one of the
major histopathological abnormalities in the early course of many
forms of glomerulonephritis. Our observations add to a list of few
reported biological functions of Egr-1. Egr-1 is essential for and
restricts differentiation of HL6O cells along the macrophage
lineage [8]. In addition to its role in macrophage differentiation,
Egr-1 was implicated, albeit only indirectly, in the differentiation
process of megakaryocytes [32]. More in line with our observa-
tions, some studies have implicated Egr-l in growth control. Sells
et al demonstrated that Egr-l impedes IL-I-inducible tumor
growth arrest in melanoma cells and that a dominant negative
mutant WT-1!Egr-I chimera accelerated growth arrest [33]. Over-
expression of Egr-1 in LLC-PK1 cells, a renal epithelial cell line,
accelerated growth rate possibly via induction of the guaninc
nucleotide binding protein Gai2 [181. Further evidence for a
possible role of Egr-1 in proliferative processes came from studies
on the ras/MAP kinase cascade, known to he critical for mitogenic
signaling. McMahon et al showed that expression of activated
p21ras results in Egr-i up-regulation and overexpression of a
dominant negative p21ras mutant inhibits Egr-1 induction [34].
Hipskind et al showed that MAP kinase leads to phosphorylation
of Elk-i, a DNA binding protein which assembles with the serum
response factor (SRF) over the serum response elements (SREs)
in the promotor region of the c-fos and also the Egr-i gene.
Phosphorylation of Elk-I was necessary for transactivating activity
of this transcription factor complex [35]. Interestingly, it was
demonstrated in various cell types, and we have shown in MCs
that the SREs in the Egr-l promotor region are critical for
transcriptional induction of Egr-i [11, 36, 37]. Therefore, these
studies establish a possible link between mitogen receptor gener-
ated second messenger systems, the activation of the MAP kinase
cascade, and the transcriptional activation of the immediate early
gene Egr-1.
To our knowledge, our study is one of the first that describes a
function of Egr-I in in vitro studies and provides evidence for clear
up-regulation in the corresponding cell type in an in vivo model.
Further studies should now address the question of whether
inhibition of Egr-I in the in vivo model of glomerulonephritis by
gene transfer techniques will be helpful in limiting the prolifera-
tive response of MCs. Furthermore, downstream target genes of
the transcriptional activator Egr-i need to be identified to obtain
more insight into the early nuclear signal transduction events
involved in MC mitogenesis.
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